SUNPHARMA Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > sunpharma

Technical Analysis

Technical Strength: 8.25 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 68.9. According to RSI analysis, sunpharma is strong. 7.0 SUNPHARMA RSI Chart
MACD (?) MACD: 5.76 and Signal Line: -7.89. According to MACD analysis, sunpharma is technically strong. 8.0 SUNPHARMA MACD Chart
Simple Moving Average (?) According to simple moving average analysis, sunpharma is in a uptrend. Support level is at 415. 9.0 SUNPHARMA Simple Moving Average Chart
Exponential Moving Average (?) Price just got above it's 200-day exponential moving average which is a positive signal. According to exponential moving average analysis, sunpharma is in a uptrend. Support level is at 418. 9.0 SUNPHARMA Exponential Moving Average Chart
Bollinger Bands (?) %b is 1.14. According to bollinger bands, sunpharma has hit the upper band which is a positive signal. 9.0 SUNPHARMA Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, no levels identified. NA SUNPHARMA Fibonacci Retracement Chart
Average True Range (?) ATR: 29.3 NA SUNPHARMA Average True Range Chart
Average Directional Index (?) ADX is 26.8 which means SUNPHARMA is in a trend. NA SUNPHARMA Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
April 09, 2020
Open Price 454.4
High Price 473.9
Low Price 443.4
Close Price 454.45
Absolute Change 17.75
Percentage Change 4.06%
Weekly Change 29%
Monthly Change 15.5%
Yearly Change -5.1%
52-week high 484.25
52-week low 312.0
Corporate Actions
ExDate Purpose
February 17, 2020 INT DIV-RS 3 PER SH
August 20, 2019 AGM/DIV-RS 2.75 PER SH
September 17, 2018 AGM/DIV RS 2 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.622
Confidence in Beta2.24%
Market Capital Rs. 94115.0 Cr
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 09 April 2020: Deliverable Quantity:7.17e+06 NA SUNPHARMA Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 09 April 2020: Daily Volatility:0.9361 NA SUNPHARMA Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 09 April 2020: PCR_OI:0.667 PCR:0.56 NA SUNPHARMA PCR Chart
Option Pain (?) 09 April 2020: Max Pain:400.0 NA SUNPHARMA Option Pain Chart
Premium (?) 09 April 2020 Premium: 1.55 Futures OI:48668750.0 NA SUNPHARMA Premium Chart
Option_MAX_OI (?) 09 April 2020: Price:454.45 Put with maximum OI:450.0 Call with maximum OI:500.0 NA SUNPHARMA Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
April 30, 2020 456.0 48668750.0 29244.0 29244.0 454.45
May 28, 2020 457.3 500000.0 476.0 476.0 454.45
June 25, 2020 458.0 7500.0 8.0 8.0 454.45


September 12, 2018 News Clarification The Exchange has sought clarification from the Company with respect to news item captioned-Sun Pharma Mohali plant on FDA radar In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.
April 26, 2018 SShareholders meetingSun Pharmaceutical Industries Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on Jun 01, 2018
See all Announcements

Board Meetings

Date Meeting Date Purpose
March 13, 2020 March 17, 2020 Buyback To consider, inter alia, the proposal for buy-back of fully paid-up equity shares of the Company, which would include maximum amount, maximum number of equity shares, mode of buy-back and other matters incidental thereto in accordance with the provisions of Section 68, 69 and 70 of the Companies Act,2013, read with rules made thereto and Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018.
February 03, 2020 February 06, 2020 Dividend Consider declaration of Interim Dividend on the equity shares of the Company, for the Financial Year 2019-2020.
See all Board Meetings

SUNPHARMA is part of...

Index Weightage

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play